The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Atara Biotherapeutics, Inc. Common 046513107 226 10,543 SH   SOLE   10,543 0 0
Editas Medicine Common 28106W103 490 36,362 SH   SOLE   36,362 0 0
LendingClub Corp. Common 52603A109 6,547 1,059,334 SH   SOLE   1,059,334 0 0
Range Recources Corp. Common 75281A109 9,181 236,920 SH   SOLE   236,920 0 0
Sage Therapeutics, Inc. Common 78667J108 3,369 73,168 SH   SOLE   73,168 0 0
SolarCity Corporation Common 83416T100 565 28,870 SH   SOLE   28,870 0 0
Trevena, Inc. Common 89532E109 2,104 311,650 SH   SOLE   311,650 0 0
Finjan Holdings, Inc. Common 31788H303 7,331 4,303,435 SH   SOLE   4,303,435 0 0
Wayfair, Inc. Common 94419L101 151,325 3,843,669 SH   SOLE   3,843,669 0 0